CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
CHINA PHARMA HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.69−0.02 (-3.49%)
Close on Oct 19, 2026
- Market cap
- $27.76M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.5%
0M of 43M shares
Institutional holders
8
3 new, 1 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Streeterville Capital LLC | 3,291,872 | 9.99% | 13G (passive) amendment | Jan 12, 2024 |
| Tao Liu | 15,000,000 | 27.30% | 13G (passive) | Dec 28, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CPHI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 125,445 | 0.29% | $82.81K | +112,521 | 0.00% |
| Two Sigma Securities, LLC | 35,666 | 0.08% | $23.54K | New | 0.00% |
| Renaissance Technologies LLC | 15,045 | 0.03% | $9.93K | +3,627 | 0.00% |
| Jane Street Group, LLC | 13,886 | 0.03% | $9.17K | New | 0.00% |
| Ground Swell Capital, LLC | 10,610 | 0.02% | $7.00K | New | 0.01% |
| UBS Group AG | 3,109 | 0.01% | $2.05K | +2,720 | 0.00% |
| EFG International AG | 40 | 0.00% | $26 | – | 0.00% |
| Danske Bank A/S | 1 | 0.00% | $1 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 8 | 0M | 0.5% | 3 / 3 | 0 / 1 | 0M | 0M |
| Q1 2026 | 6 | 0M | 0.1% | 2 / 1 | 1 / 1 | 0M | 0M |
| Q4 2025 | 5 | 0M | 0.1% | 2 / 1 | 1 / 2 | 0M | 0M |
| Q3 2025 | 5 | 0M | 0.1% | 2 / 1 | 1 / 2 | 0M | 0M |
| Q2 2025 | 5 | 0M | 0.3% | 5 / 0 | 0 / 0 | 0M | 0M |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Zhilin Li CEO & Interim CFO, Director, 10% owner | Sep 29, 2023 | Award | +13,757,063 | $0.14 | $1.93M | 15,138,063 |
| Zhilin Li CEO & Interim CFO, Director, 10% owner | Sep 9, 2021 | Award | +1,760,000 | $0.67 | $1.18M | 13,810,000 |
| Zhilin Li CEO and interim CFO, Director, 10% owner | Dec 23, 2020 | Award | +2,000,000 | – | – | 12,050,000 |
| Frank Waung Chief Financial Officer | Apr 28, 2012 | Award | +100,000 | – | – | 138,415 |
| Frank Waung Chief Financial Officer | May 25, 2011 | Award | +25,000 | – | – | 38,415 |
| Zhilin Li President and CEO, Director, 10% owner | May 25, 2011 | Award | +50,000 | – | – | 10,050,000 |
| Frank Waung Chief Financial Officer | Dec 13, 2010 | Award | +6,863 | – | – | 13,415 |
| Frank Waung Chief Financial Officer | Nov 15, 2010 | Option exercise | +4,052 | – | – | 6,552 |
| Heung Mei Tsui Director, 10% owner | Feb 9, 2010 | Award | −1,500,000 | $3.00 | $4.50M | 9,312,651 |
| Heung Mei Tsui Director, 10% owner | Nov 26, 2007 | Award | −4,465,734 | $1.52 | $6.79M | 10,812,651 |
| Zhilin Li President and CEO, Director, 10% owner | Sep 13, 2006 | Award | +10,000,000 | – | – | 10,000,000 |
| Heung Mei Tsui Director, 10% owner | Sep 13, 2006 | Award | −10,000,000 | – | – | 15,278,385 |
| Heung Mei Tsui Director, 10% owner | May 16, 2006 | Award | +4,723,056 | – | – | 25,278,385 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.